157 related articles for article (PubMed ID: 8723103)
1. Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta.
Dyne KM; Valli M; Forlino A; Mottes M; Kresse H; Cetta G
Am J Med Genet; 1996 May; 63(1):161-6. PubMed ID: 8723103
[TBL] [Abstract][Full Text] [Related]
2. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
3. Mutations in type I collagen genes resulting in osteogenesis imperfecta in humans.
Gajko-Galicka A
Acta Biochim Pol; 2002; 49(2):433-41. PubMed ID: 12362985
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta.
Fedarko NS; Moerike M; Brenner R; Robey PG; Vetter U
J Bone Miner Res; 1992 Aug; 7(8):921-30. PubMed ID: 1442206
[TBL] [Abstract][Full Text] [Related]
5. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
Lund AM; Skovby F; Schwartz M
Hum Mutat; 1997; 9(5):431-6. PubMed ID: 9143923
[TBL] [Abstract][Full Text] [Related]
6. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
[TBL] [Abstract][Full Text] [Related]
7. Molecular heterogeneity in osteogenesis imperfecta type I.
Willing MC; Pruchno CJ; Byers PH
Am J Med Genet; 1993 Jan; 45(2):223-7. PubMed ID: 8456806
[TBL] [Abstract][Full Text] [Related]
8. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
9. Thirty-three novel COL1A1 and COL1A2 mutations in patients with osteogenesis imperfecta types I-IV.
Ward LM; Lalic L; Roughley PJ; Glorieux FH
Hum Mutat; 2001 May; 17(5):434. PubMed ID: 11317364
[TBL] [Abstract][Full Text] [Related]
10. Chemical cleavage method for the detection of RNA base changes: experience in the application to collagen mutations in osteogenesis imperfecta.
Bateman JF; Lamande SR; Hannagan M; Moeller I; Dahl HH; Cole WG
Am J Med Genet; 1993 Jan; 45(2):233-40. PubMed ID: 8456808
[TBL] [Abstract][Full Text] [Related]
11. Identification of decorin proteoglycan in bovine tracheal serous cells in culture and localization of decorin mRNA in situ.
Brahimi-Horn MC; Deudon E; Paul A; Mergey M; Mailleau C; Basbaum C; Dohrman A; Capeau J
Eur J Cell Biol; 1994 Aug; 64(2):271-80. PubMed ID: 7813515
[TBL] [Abstract][Full Text] [Related]
12. Osteogenesis imperfecta: changes in noncollagenous proteins in bone.
Vetter U; Fisher LW; Mintz KP; Kopp JB; Tuross N; Termine JD; Robey PG
J Bone Miner Res; 1991 May; 6(5):501-5. PubMed ID: 2068957
[TBL] [Abstract][Full Text] [Related]
13. Expression of decorin and collagens I and III in different layers of human skin in vivo: a laser capture microdissection study.
Lochner K; Gaemlich A; Südel KM; Venzke K; Moll I; Knott A; Stäb F; Wenck H; Döring O; Böttger M; Gallinat S
Biogerontology; 2007 Jun; 8(3):269-82. PubMed ID: 17146610
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.
Dodge GR; Diaz A; Sanz-Rodriguez C; Reginato AM; Jimenez SA
Arthritis Rheum; 1998 Feb; 41(2):274-83. PubMed ID: 9485085
[TBL] [Abstract][Full Text] [Related]
15. Osteogenesis imperfecta mutations may probe vital functional domains (e.g. proteoglycan binding sites) of type 1 collagen fibrils.
Scott JE; Tenni R
Cell Biochem Funct; 1997 Dec; 15(4):283-6. PubMed ID: 9415975
[TBL] [Abstract][Full Text] [Related]
16. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis.
Rühland C; Schönherr E; Robenek H; Hansen U; Iozzo RV; Bruckner P; Seidler DG
FEBS J; 2007 Aug; 274(16):4246-55. PubMed ID: 17651433
[TBL] [Abstract][Full Text] [Related]
17. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
Galicka A; Wołczyński S; Gindzieński A
Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
[TBL] [Abstract][Full Text] [Related]
18. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
[TBL] [Abstract][Full Text] [Related]
19. Serine for glycine substitutions in the C-terminal third of the alpha 1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta.
Lund AM; Skovby F; Schwartz M
Hum Mutat; 1997; 9(4):378-82. PubMed ID: 9101304
[No Abstract] [Full Text] [Related]
20. Substitution of arginine for glycine at position 154 of the alpha 1 chain of type I collagen in a variant of osteogenesis imperfecta: comparison to previous cases with the same mutation.
Zhuang J; Tromp G; Kuivaniemi H; Castells S; Prockop DJ
Am J Med Genet; 1996 Jan; 61(2):111-16. PubMed ID: 8669434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
